Top Markets
Coin of the day
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
株式のランク #34154
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
株価
$0.617
最終同期: 2024-10-14
時価総額
$6.13M
変化(1日)
0.49%
変化(1年)
0.00%
US
取引 Kineta, Inc. (KA)

カテゴリー

Kineta, Inc.(KA)の収益
Mar 2025 時点の収益 TTM: $4.34M
Kineta, Inc. の最新の財務報告によると、現在の収益 (TTM) は $4.34M です。2023 年には $5.44M の収益があり、これは 2022 年の $1.95M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Kineta, Inc. の収益履歴(2015 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $4.34M 0.00%
2024 0.00 -100.00%
2023 $5.44M 178.65%
2022 $1.95M -78.52%
2021 $9.09M -13.32%
2020 $10.49M 109.76%
2019 $5.00M 76.06%
2018 $2.84M -46.83%
2017 $5.34M -36.30%
2016 $8.38M 94.43%
2015 $4.31M 0.00%
同業他社の収益
企業 収益 収益の差
$12.62B 290,916.60%
US
$6.02B 138,703.30%
NL
- -
CH
- -
KR
$10.11B 232,974.84%
BE